Viatical Settlements: Selling a Life Insurance Policy When Terminally Ill

Receiving 50%–80% of a Death Benefit While Still Alive

A viatical settlement allows the owner of a life insurance policy to sell that policy to a third-party investor for an immediate lump sum payment that is typically 50%–80% of the policy's face value. The buyer pays the remaining premiums, becomes the new policy owner and beneficiary, and collects the full death benefit when the original insured dies. Viatical settlements were developed in the late 1980s during the AIDS crisis as a mechanism for terminally ill policyholders—who urgently needed cash and had little use for a death benefit they would never see—to access the economic value trapped in their life insurance while they were still alive.

The name derives from the Latin viaticum—provisions for a journey—historically the Eucharist given to a dying person. Today, viatical settlements are regulated financial transactions in most U.S. states, with licensing requirements for providers and brokers and mandatory disclosure obligations. The decision to sell a life insurance policy is significant and largely irreversible; understanding the full mechanics, pricing, tax implications, and alternatives is essential before proceeding.

Who Qualifies for a Viatical Settlement

Viatical settlements are available to individuals with a terminal or chronic illness, which distinguishes them from life settlements (available to any policyholder typically over age 65 with reduced life expectancy). The illness criteria vary by state and by the individual provider, but the general standard is:

A physician must certify the qualifying illness and life expectancy. Life expectancy assessment is often supplemented by an independent medical underwriting company hired by the viatical provider. The shorter the projected life expectancy, the higher the offer percentage—because the buyer expects to hold the policy (and pay premiums) for a shorter period before collecting the death benefit.

How Viatical Settlement Pricing Works

The purchase price offered by a viatical settlement provider reflects a calculated yield expectation based on three primary variables: the policy's face value, the ongoing premium cost, and the projected time until the insured's death.

• Face value: The death benefit the buyer will eventually receive. Higher face value means larger potential offer amounts. Policies below $100,000 face value are often uneconomical for providers; the market is most active for policies of $250,000 and above.
• Premium cost: The buyer assumes future premium payments. High ongoing premiums reduce the offer percentage because they increase the buyer's total cost basis. Universal life policies with flexible premiums can be structured to minimize ongoing cost; term policies near expiration may generate no viable offer because the remaining term is shorter than projected life expectancy.
• Life expectancy: The central pricing variable. A 12-month life expectancy might produce an offer of 70%–80% of face value. A 24-month expectancy might produce 50%–65%. Providers model internal rates of return—they are targeting yields of 10%–25% depending on market conditions and competition.

The Role of a Viatical Broker

Viatical brokers act as intermediaries between the policy owner and multiple providers, submitting the policy to competitive bidding to maximize the offered price. Brokers typically earn fees of 2%–6% of the face value, paid by the provider (not the seller), though this cost is factored into the provider's offer calculation. Working with a licensed broker generally produces higher offers than approaching a single provider directly—competitive pressure among buyers is the primary mechanism for improving the seller's outcome.

Tax Treatment of Viatical Settlement Proceeds

Federal tax treatment of viatical settlement proceeds is generally favorable for qualifying terminally ill individuals. Under the Health Insurance Portability and Accountability Act of 1996 (HIPAA), amounts received through a viatical settlement are excluded from gross income if the insured is terminally ill (certified life expectancy of 24 months or less) or chronically ill (as defined under Section 7702B of the tax code).

• For terminally ill individuals: The full proceeds are excludable from federal income tax, regardless of the policy's cost basis or the amount of gain over basis.
• For chronically ill individuals: The exclusion applies if proceeds are used for long-term care expenses; amounts used for other purposes may be subject to tax.
• For non-qualifying sellers: If the insured does not meet terminal or chronic illness criteria (more relevant to life settlements than viatical settlements), gains above cost basis are taxable—a portion as ordinary income, a portion as capital gain, depending on the specific tax treatment rules.
• State tax treatment: Most states follow federal treatment, but some impose state income tax on proceeds; consult a tax professional for state-specific rules.

Regulatory Environment

Viatical settlements are regulated at the state level under the National Association of Insurance Commissioners (NAIC) model act, adopted in various forms by the majority of states. Regulation typically requires:

• Licensing of both viatical settlement providers and brokers
• Mandatory disclosure of all terms, alternatives, and the seller's rights
• A rescission period (typically 15–30 days) during which the seller can cancel the transaction and recover the policy
• Prohibition of fraud, misrepresentation, and rebating
• Restrictions on advertising targeting vulnerable populations

Despite regulation, consumer protection concerns persist. High-pressure sales tactics, lowball offers from providers operating in less competitive markets, and complex policy mechanics (particularly with universal life policies where the cash value affects offer calculations) create opportunities for sellers to receive less than fair market value. Independent legal and financial advice before proceeding is strongly recommended.

Alternatives to Viatical Settlements

Before proceeding with a viatical settlement, terminally ill policyholders should evaluate every available alternative, as each may provide better economics in specific circumstances.

• Accelerated Death Benefit (ADB) rider: Many life insurance policies include a rider allowing the insured to receive 25%–100% of the death benefit while terminally ill, directly from the insurer. ADB proceeds are also tax-free under HIPAA. ADB typically requires a life expectancy of 12–24 months and returns 50%–90% of face value with no transaction costs or middlemen.
• Policy loan: Universal and whole life policies with accumulated cash value can be borrowed against without surrendering the policy. Loans are not taxable, and the policy remains active—if the insured recovers, the loan can be repaid and the death benefit preserved for beneficiaries.
• Surrendering for cash value: If the policy has significant cash value, surrendering it directly to the insurer avoids viatical provider fees but yields only the cash value, which may be substantially less than the death benefit.
• Government and nonprofit assistance programs: Medicaid, Medicare, Social Security Disability, and disease-specific nonprofit organizations may provide financial resources without requiring the sale of a life insurance asset.

This article is for informational purposes only and does not constitute financial advice.